Norepinephrine Market

Norepinephrine (NE), also called noradrenaline (NA) or noradrenalin, is an organic chemical in the catecholamine family that functions in the brain and body as a hormone and neurotransmitter. Norepinephrine also called noradrenaline is both a hormone, produced by the adrenal glands, and a neurotransmitter, a chemical messenger which transmits signals across nerve endings in the body. Norepinephrine is produced in the inner part of the adrenal glands, also called the adrenal medulla. The adrenal medulla also makes adrenaline (also known as epinephrine). Norepinephrine, adrenaline and dopamine belong are part of the catecholamine family. Adrenal glands are making primarily adrenaline and most of the norepinephrine in the blood comes from nerve endings. It plays a role in your mood and ability to concentrate.

Norepinephrine Market contains market size and forecasts of Norepinephrine (Noradrenaline) in Global, including the following market information:

Global Norepinephrine (Noradrenaline) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Norepinephrine (Noradrenaline) market was valued at 408.5 million in 2021 and is projected to reach US$ 863.9 million by 2028, at a CAGR of 11.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

2mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Norepinephrine (Noradrenaline) include Pfizer, Novartis, Teva, Amneal Biosciences, Baxter, Mylan, Hikma Pharmaceuticals, Shanghai Harvest and Grand Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Norepinephrine (Noradrenaline) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Norepinephrine (Noradrenaline) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Norepinephrine (Noradrenaline) Market Segment Percentages, by Type, 2021 (%)

• 2mg
• 4mg
• Other

Global Norepinephrine (Noradrenaline) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Norepinephrine (Noradrenaline) Market Segment Percentages, by Application, 2021 (%)

• Shock Hypotensive
• AMI Hypotension
• Other

Global Norepinephrine (Noradrenaline) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Norepinephrine (Noradrenaline) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Norepinephrine (Noradrenaline) revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies Norepinephrine (Noradrenaline) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Novartis
• Teva
• Amneal Biosciences
• Baxter
• Mylan
• Hikma Pharmaceuticals
• Shanghai Harvest
• Grand Pharmaceutical
• King York